BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Friday, February 13, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 23, 2015
View Archived Issues
BTZ-169 active in tuberculosis model, phase I study planned
Read More
Models reveal role of epoxyeicosatrienoic acids in hematopoietic stem and progenitor cell transplant
Read More
Deciphera closes Series B financing
Read More
Corbus starts enrolling adults with CF into phase II trial of Resunab
Read More
SOFIA transgenic pig enables study of insulin secretory granule processing
Read More
Clinical outcomes reported for triheptanoin in rare metabolic disorders
Read More
Armetheon and Lee's Pharma to develop tecarfarin in China and Thailand
Read More
European Commission approves Zalviso for acute moderate to severe postoperative pain
Read More
H3 Biomedicine and Selvita prolong collaboration for cancer medicines
Read More
AB Science stops phase III study of masitinib in rheumatoid arthritis
Read More
Intra-Cellular Therapies announces end of phase I for ITI-214 and initiates public share offer
Read More
International Progressive MS Alliance grants planning awards to advance efforts in progressive MS
Read More
AbbVie reports 5-HT2C receptor agonists
Read More
Kallikrein inhibitors described in BioCryst Pharmaceuticals patent
Read More
Nagoya City University divulges antimalaria agents
Read More
Bristol-Myers Squibb patents MGAT2 inhibitors
Read More
GlaxoSmithKline introduces EZH2 inhibitors
Read More
Antibacterial compounds in early development at Actelion Pharmaceuticals
Read More
Susan G. Komen announces new grants for breast cancer research
Read More
FDA approves Lonsurf for refractory metastatic colorectal cancer
Read More
KCNJ10 gene polymorphism identified in childhood epilepsy
Read More
Phase I trial explores HPV-16/18 E6/E7-specific T lymphocytes in patients with relapsed HPV cancers
Read More
In vitro and in vivo activity of BPI-7711 against EGFR-mutated NSCLC
Read More
ZP-I-98: a novel GIP receptor agonist
Read More
Promising topline results from phase II study of HTX-011 for postoperative pain
Read More
RuiYi initiates first human dosing of gerilimzumab
Read More
